Cryogenic logistics for fertility services
Cryoport, which specialises in logistics services for the cell and gene therapy sector, has signed a three-year supply chain solutions agreement with Monash IVF Group, a provider of assisted reproductive services, as well as specialist women's imaging and diagnostic services in Australia and Southeast Asia.
Under this multi-year agreement, Monash IVF and its operating businesses will utilise Cryoport's cryogenic logistics solutions and ISO-certified risk mitigation process for the delivery of patients' reproductive materials in Australia and internationally.
Jerrell Shelton, CEO of Cryoport: "By joining forces and bringing our solutions and expertise to Monash IVF, we have the opportunity to support many more individuals and families throughout Australia and Southeast Asia in their plans to become parents." (mk)